DSM-IV Axis-I comorbidity among illicit drug users seeking treatment for substance use disorders: Results from the Multi-centre Study of Psychiatric Comorbidity in Drug Addicts (MUPCDA)

Mental Health and Substance Use: Dual Diagnosis

Volumn 3, Issue 3, 2010, Pages 182-192

  Thomasius, Rainer ^a   Sack, Peter Michael ^a   Petersen, Kay Uwe ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

clinical sample; comorbidity; drug dependence; IDDT; multi centre study

Indexed keywords

ALCOHOL; AMPHETAMINE; CANNABIS; COCAINE; DIHYDROCODEINE; METHADONE; OPIATE; PSYCHEDELIC AGENT; SEDATIVE AGENT;

ADOLESCENT; ADULT; AGORAPHOBIA; ARTICLE; AUDITORY HALLUCINATION; COMORBIDITY; CRIME; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DYSTHYMIA; EATING DISORDER; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; GENERALIZED ANXIETY DISORDER; HEALTH INSURANCE; HELP SEEKING BEHAVIOR; HUMAN; INCOME; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MANIA; MARRIAGE; OBSESSIVE COMPULSIVE DISORDER; PANIC; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PRIORITY JOURNAL; SOCIAL PHOBIA; SOMATIZATION; UNEMPLOYMENT; VISUAL HALLUCINATION;

EID: 77956919548     PISSN: 17523281     EISSN: 17523273     Source Type: Journal    
DOI: 10.1080/17523281.2010.504643     Document Type: Article

References (41)

1. American Psychaitric Association. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV. Washington, DC: American Psychaitric Association.
2. Backmund, M., Meyer, K., Eichenlaub, D., & Schuetz, C.G. (2001). Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients. Drug and Alcohol Dependence, 64, 173-180.
3. Beaumont, C., Charbonneau, R., Delisle, J., Landry, A., Ménard, J.M., Paquette, D., et al. (2005). Toxicomanie, jeu pathologique et troubles mentaux: Pour une intervention efficace des centres et de leurs partenaires. Montréal: Fédération québécoise des centres de réadaptation pour personnes alcooliques et autres toxicomanes. Retrieved February 4, 2010, from: http://www.fqcrpat.org/upload/doc/doc51.pdf.
4. Bizarri, J., Rucci, P., Vallotta, A., Girelli, M., Scandolari, A., Zerbetto, E., et al. (2005). Dual diagnosis and quality of life in patients in treatment for opioid dependence. Substance Use & Misuse, 40, 1765-1776.
5. Brooner, R.K., King, V.L., Kidorf, M., Schmidt, C.W. Jr., & Bigelow, G.E. (1997). Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Archives of General Psychiatry, 54, 71-80.
6. Brunette, M.F., Mueser, K.T., & Drake, R.E. (2004). A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders. Drug and Alcohol Review, 23, 471-481.
7. Bryant, K.J., Rounsaville, B., Spitzer, R.L., & Williams, J.B.W. (1992). Reliability of dual diagnosis - substance dependence and psychiatric disorders. Journal of Nervous and Mental Disease, 180, 251-257.
8. Cacciola, J.S., Alterman, A.I., Rutherford, M.J., McKay, J.R., & Mulvaney, F.D. (2001). The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug and Alcohol Dependence, 61, 271-280.
9. Compton, W.M., Cottler, L.B., Ridenour, T., Ben-Abdallah, A., & Spitznagel, E.L. (2002). The specificity of family history of alcohol and drug abuse in cocaine abusers. American Journal on Addictions, 11, 85-94.
10. Clerici, M., Carta, I., & Cazzullo, C.L. (1989). Substance abuse and psychopathology. A diagnostic screening of Italian narcotic addicts. Social Psychiatry and Psychiatric Epidemiology, 24, 219-226.
11. DiNardo, P.A., & Barlow, D.H. (1988). Anxiety Disorders Interview Schedule - revised (ADIS-R). Albany, NY: Graywind Publications.
12. Drake, R.E., Essock, S.M., Shaner, A., Carey, K.B., Minkoff, K., Kola, L., et al. (2001). Implementing dual diagnosis services for clients with severe mental illness. Psychiatric Services, 52, 469-476.
13. Drake, R.E., Xie, H., McHugo, G.J., & Shumway, M. (2004). Three-year outcomes of longterm patients with co-occurring bipolar and substance use disorders. Biological Psychiatry, 56, 749-756.
14. Farrell, M., Howes, S., Bebbington, P., Brugha, T., Jenkins, R., Lewis, G., et al. (2001). Nicotine, alcohol and drug dependence and psychiatric comorbidity - Results of a national household survey. British Journal of Psychiatry, 179, 432-437.
15. Frei, A., & Rehm, J. (2002). The prevalence of psychiatric comorbidity among opioid addicts. A quantitative meta-analysis. [In German.] Psychiatrische Praxis, 29, 258-262.
16. Kandel, D.B., Huang, F.Y., & Davies, M. (2001). Comorbidity between patterns of substance use dependence and psychiatric syndromes. Drug and Alcohol Dependence, 64, 233-241.
17. Kêdoté,M.N., Brousselle, A., & Champagne, F. (2008). Use of health care services by patients with co-occurring severe mental illness and substance use disorders. Mental Health and Substance Use: dual diagnosis, 1, 216-227.
18. Kessler, R.C. (2004). The epidemiology of dual diagnosis. Biological Psychiatry, 56, 730-737.
19. Kessler, R.C., McGonagle, K.A., Zhao, S., Nelson, C.B., Hughes, M., Eshleman, S., et al. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry, 51, 8-19.
20. Kessler, R.C., Nelson, C.B., McGonagle, K.A., Edlund, M.J., Frank, R.G., & Leaf, P.J. (1996). The epidemilogy of co-occurring addictive and mental disorders: implications for prevention and service utilization. American Journal of Orthopsychiatry, 66, 17-31.
21. Kidorf, M., Disney, E.R., King, V.L., Neufeld, K., Beilenson, P.L., & Brooner, R.B. (2004). Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug and Alcohol Dependence, 74, 115-122.
22. Lieb, R., & Isensee, B. (2002). Haeufigkeit und zeitliche Muster von Komorbiditaet [Prevalences and courses of co-morbidity]. In F. Moggi (Ed.), Doppeldiagnosen [Dual diagnoses] (pp. 31-62). Bern: Huber.
23. Manning, V., Strathdee, G., Best, D., Keaney, F., Bhui, K., & Gossop, M. (2008). Differences in mental health, substance use, and other problems among dual diagnosis patients attending psychiatric or substance misuse treatment services. Mental Health and Substance Use: dual diagnosis, 1, 54-63.
24. Margraf, J. (1994). Mini-DIPS. [Short Diagnostic Interview for Psychological Disorders (2nd ed.)]. PSYNDEXplus - Tests 1977-2005/06. Accession number 3357.
25. Margraf, J., Schneider, S., & Ehlers, A. (1991). Diagnostisches Interview bei psychischen Störungen (DIPS). [Diagnostic Interview for Psychological Disorders]. Berlin: Springer.
26. Marsden, J., Gossop, M., Stewart, D., Rolfe, A., & Farrell, M. (2000). Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment Outcome Research Study. British Journal of Psychiatry, 176, 285-289. (Pubitemid 30179850)
27. Mason, B.J., Kocsis, J.H., Melia, D., Khouri, E.T., Sweeney, J., Wells, A., et al. (1998). Psychiatric comorbidtiy in methadone maintained patients. Journal of Addictive Diseases, 17, 75-89.
28. McLellan, A.T., & Meyers, K. (2004). Contemporary addiction treatment: A review of systems problems for adults and adolescents. Biological Psychiatry, 56, 764-770.
29. Milby, J.B., Sims, M.K., Khuder, S., Schumacher, J.E., Huggins, N., McLellan, A.T., et al. (1996). Psychiatric comorbidity: Prevalence in methadone maintenance treatment. American Journal of Drug and Alcohol Abuse, 22, 95-107.
30. Minkoff, K. (2001). Behavioral health recovery management: Service planning guidelines, co-occurring psychiatric and substance disorders. University of Chicago Center for Psychiatric Rehabilitation, Chicago, IL. Retrieved April 11, 2005, from http://www. bhrm.org/guidelines/Minkoff.pdf
31. OBrien, C.P., Charney, D.S., Lewis, L., Cornish, J.W., Post, R.M., Woody, G.E., et al. (2004). Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: A call to action. Biological Psychiatry, 56, 703-713.
32. Regier, D.A., Burke, X. Jr., & Burke, K.C. (1990a). Comorbidity of affective and anxiety disorders in the NIMH Epidemiologic Catchment Area. In J.D. Maser & C.R. Cloninger (Eds.), Comorbidity of mood and anxiety disorders (pp. 113-122). Washington, DC: American Psychiatric Press.
33. Regier, D.A., Farmer, M.E., Rae, D.S., Locke, B.Z., Krith, S.J., Judd, L.L., & Goodwin, F.K. (1990b). Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association, 264, 2511-2518.
34. Samet, S., Nunes, E.V., & Hasin, D. (2004). Diagnosing comorbidity: Concepts, criteria, and methods. Acta Neuropsychiatrica, 16, 9-18.
35. Schaar, I., & Ojehagen, A. (2001). Severely mentally ill substance abusers: An 18-month follow-up study. Social Psychiatry and Psychiatric Epidemiology, 36, 70-78.
36. Schneider, U., Altmann, A., Baumann, M., Bernzen, J., Bertz, B., Bimber, U., et al. (2001). Comorbid anxiety and affective disorder in alcohol-dependent patients seeking treatment: The first Multicentre Study in Germany. Alcohol and Alcoholism, 36, 219-223.
37. Simon, R., Spegel, H., Huellinghorst, R., Noecker, G., & David-Spickermann, M. (2001). Report to the EMCDDA by the REITOX National Focal Point Germany: Drug situation 2001. German Reference Centre for the European Monitoring Centre for Drugs and Drug Addiction DBDD. Retrieved April 11, 2005, from http://www.dbdd.de/Download/ REITOX-D2002-E-finb.pdf
38. Skinstad, A.H., & Swain, A. (2001). Comorbidity in a clinical sample of substance abusers. American Journal of Drug and Alcohol Abuse, 27, 45-64.
39. Sowers, W., & Golden, S. (1999). Psychotropic medication management in persons with co-occurring psychiatric and substance use disorders. Journal of Psychoactive Drugs, 31, 59-70.
40. Wamel, A., van, Kroon, H., & Rooijen, S. van (2008). Systematic implementation of integrated dual disorders treatment in The Netherlands. Mental Health and Substance Use: dual diagnosis, 2, 101-110.
41. Watkins, K.E., Burnam, A., Kung, F.Y., & Paddock, S. (2001). A national survey of care for persons with co-occurring mental and substance use disorders. Psychiatric Services, 52, 1062-1068.